Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Hematological Oncology
|
April 30, 2014
Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy
Lewis R Silverman, Peter Greenberg, Azra Raza, et al.
Scientific Reports
|
March 15, 2016
Effects of Systemically Administered Hydrocortisone on the Human Immunome
Matthew J Olnes, Yuri Kotliarov, Angélique Biancotto, et al.
Plos One
|
December 19, 2013
Baseline levels and temporal stability of 27 multiplexed serum cytokine concentrations in healthy subjects
Angelique Biancotto, Abigail Wank, Shira Perl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2010
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions
Elaine M Sloand, Matthew J Olnes, Aarthie Shenoy, et al.
Transfusion
|
September 3, 2011
Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors
Matthew J Olnes, Andrea Poon, Susan J Miranda, et al.
Blood
|
December 19, 2013
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug
Ronan Desmond, Danielle M Townsley, Bogdan Dumitriu, et al.
Genes & Cancer
|
August 19, 2010
A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition
Shashidhar S Jatiani, Stephen C Cosenza, M V Ramana Reddy, et al.
Cell
|
April 15, 2014
Global analyses of human immune variation reveal baseline predictors of postvaccination responses
John S Tsang, Pamela L Schwartzberg, Yuri Kotliarov, et al.
The New England Journal of Medicine
|
July 6, 2012
Eltrombopag and improved hematopoiesis in refractory aplastic anemia
Matthew J Olnes, Phillip Scheinberg, Katherine R Calvo, et al.
Leukemia Research
|
April 25, 2012
Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na
Matthew J Olnes, Aarthie Shenoy, Barbara Weinstein, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Hematological Oncology
|
April 30, 2014
Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy
Lewis R Silverman, Peter Greenberg, Azra Raza, et al.
Scientific Reports
|
March 15, 2016
Effects of Systemically Administered Hydrocortisone on the Human Immunome
Matthew J Olnes, Yuri Kotliarov, Angélique Biancotto, et al.
Plos One
|
December 19, 2013
Baseline levels and temporal stability of 27 multiplexed serum cytokine concentrations in healthy subjects
Angelique Biancotto, Abigail Wank, Shira Perl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2010
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions
Elaine M Sloand, Matthew J Olnes, Aarthie Shenoy, et al.
Transfusion
|
September 3, 2011
Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors
Matthew J Olnes, Andrea Poon, Susan J Miranda, et al.
Blood
|
December 19, 2013
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug
Ronan Desmond, Danielle M Townsley, Bogdan Dumitriu, et al.
Genes & Cancer
|
August 19, 2010
A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition
Shashidhar S Jatiani, Stephen C Cosenza, M V Ramana Reddy, et al.
Cell
|
April 15, 2014
Global analyses of human immune variation reveal baseline predictors of postvaccination responses
John S Tsang, Pamela L Schwartzberg, Yuri Kotliarov, et al.
The New England Journal of Medicine
|
July 6, 2012
Eltrombopag and improved hematopoiesis in refractory aplastic anemia
Matthew J Olnes, Phillip Scheinberg, Katherine R Calvo, et al.
Leukemia Research
|
April 25, 2012
Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na
Matthew J Olnes, Aarthie Shenoy, Barbara Weinstein, et al.
Page
of 3